- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- News News
- Join Join
Americans for Safe Access to Launch National Campaign to Combat Opioid Deaths and Addiction Nov 1st
WASHINGTON, DC — Today, President Trump declared the opioid crisis a public health emergency. While this is good news, this declaration does not carry the same weight as the national emergency declaration the President promised in August because it does not include the necessary provisions for new funds which states need to combat the crisis. Nor does the Administration have a substantive plan for helping the states implement a concerted effort to combat the crisis.
“We are glad that the President is finally formally recognizing that our country is indeed in a crisis,” stated Steph Sherer, Executive Director of Americans for Safe Access. “However, he failed to address the fact that one in three Americans suffer from chronic pain and one in ten have experienced severe pain every day for three months or more. The shortfalls in funding for states means it is more important than ever that Congress ensures that states can continue to run medical cannabis programs that are having an impact on this crisis that claims 91 American lives a day. States with medical cannabis programs are seeing reductions in opioid related deaths of up to 25%, and without action from Congress this year, AG Sessions could have free reign to interrupt these effective programs that are saving lives. The Administration and lawmakers need to stop ignoring the glaring evidence that medical cannabis is an important tool in addressing the opioid crisis.”
Thirty states, including those most negatively impacted by the opioid crisis such as West Virginia, New Hampshire, Ohio, and Washington DC, have medical cannabis programs which allow medical cannabis to be used to treat chronic pain. A study in the Journal of the American Medical Association indicated that in states with medical cannabis programs, there has been a 25% reduction in opioid related deaths. This study also showed a 13% decrease in hospitalizations from opioid related causes.
However, programs from these states, and the critical tool of medical cannabis to fight the opioid crisis are at risk. Medical cannabis remains illegal under federal law, but currently the Department of Justice is prohibited from spending federal dollars on prosecuting medical cannabis patients because of an annual Congressional Appropriations amendment. This protection, known as the Rohrabacher-Blumenauer amendment has been included each year since December 2014. If the Rohrabacher-Blumenauer amendment, which protects state medical cannabis programs, is allowed to expire, it is possible that many more individuals will die from opioid overdose because of a lack of safe access to alternatives to pain management.
On November 1, Americans for Safe Access, along with approximately 150 advocates will hold a press conference and rally in Upper Senate Park in Washington, DC to encourage Congress and the Administration to consider medical cannabis as an option for pain in order to help mitigate the current opioid overdose crisis. Sister rallies are planned across the country. Advocates hope that both the Administration and Congress will take measures to ensure medical cannabis states have the protections and federal support they need to utilize medical cannabis as a treatment for pain and, in turn, decrease opioid addiction and overdose in their states.